Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways

Blood

Volumn 114, Issue 14, 2009, Pages 2969-2983

  Ravoet, Marie ^a,b   Sibille, Catherine ^b   Gu, Chunyan ^a   Libin, Myriam ^a,c,d   Haibe Kains, Benjamin ^a,d   Sotiriou, Christos ^a   Goldman, Michel ^c,d   Roufosse, Florence ^c,d   Willard Gallo, Karen ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; MICRORNA; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CHRONIC DISEASE; CLONE; CONTROLLED STUDY; DISEASE COURSE; DONOR; EVOLUTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; GROWTH REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; HYPEREOSINOPHILIC SYNDROME; LYMPHOCYTES; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 70349128065     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-175091     Document Type: Article

References (59)

1. Roufosse F, Cogan E, Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):389-413.
2. Roufosse F, Schandene L, Sibille C, et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000;109(3):540-548. (Pubitemid 30415180)
3. Kitano K, Ichikawa N, Mahbub B, et al. Eosinophilia associated with proliferation of CD(3+)4- (8-) alpha beta+ T cells with chromosome 16 anomalies. Br J Haematol. 1996;92(2):315-317.
4. Bank I, Amariglio N, Reshef A, et al. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes. Leuk Lymphoma. 2001;142(1):123-133. (Pubitemid 32700930)
5. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia [see comments]. N Engl J Med. 1999;341(15):1112-1120. (Pubitemid 29466223)
6. Brugnoni D, Airo P, Rossi G, et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood. 1996;87(4):1416-1422. (Pubitemid 26056905)
7. O'Shea JJ, Jaffe ES, Lane HC, MacDermott RP, Fauci AS. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis: clinical, pathologic, and immunologic features. Am J Med. 1987;82(3):539-545.
8. Ravoet M, Sibille C, Roufosse F, et al. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica. 2005;90(6):753-765. (Pubitemid 40897217)
9. Roumier AS, Grardel N, Lai JL, et al. Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level. Haematologica. 2003; 88(7):ECR24.
10. Schandene L, Roufosse F, de Lavareille A, et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 2000;96(13):4285-4292.
11. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348(13):1201-1214. (Pubitemid 36359296)
12. Roufosse F, Schandene L, Sibille C, et al. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 1999;94(3):994-1002. (Pubitemid 29361831)
13. Zhang L, Wang L, Ravindranathan A, Miles MF. A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. J Mol Biol. 2002;317(2):225-235. (Pubitemid 34722190)
14. Kennedy RE, Kerns RT, Kong X, Archer KJ, Miles MF. SScore: an R package for detecting differential gene expression without gene expression summaries. Bioinformatics. 2006;22(10):1272-1274. (Pubitemid 43779022)
15. Willard-Gallo KE, Badran BM, Ravoet M, et al. Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Exp Hematol. 2005;33(10):1147-1159. (Pubitemid 41416963)
16. de Lavareille A, Roufosse F, Schandene L, Stordeur P, Cogan E, Goldman M. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol. 2001;31(4):1037-1046.
17. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome [see comments]. N Engl J Med. 1994;330(8):535-538. (Pubitemid 24058956)
18. Hamalainen H, Zhou H, Chou W, Hashizume H, Heller R, Lahesmaa R. Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol. 2001;2(7):RESEARCH0022.1- 0022.11.
19. Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC activated Th2 memory cells. J Exp Med. 2007; 204(8):1837-1847. (Pubitemid 47236321)
20. Caruso R, Stolfi C, Sarra M, et al. Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via a p38 Map kinase-dependent induction of SOCS-3. Blood. 2009;113(15):3512-3519.
21. Longhi MP, Harris CL, Morgan BP, Gallimore A. Holding T cells in check: a new role for complement regulators? Trends Immunol. 2006;27(2): 102-108. (Pubitemid 43221977)
22. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3(5):541-547.
23. Owaki T, Asakawa M, Fukai F, Mizuguchi J, Yoshimoto T. IL-27 induces Th1 differentiation via p38 MAPK/T-beta- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol. 2006;177(11):7579-7587. (Pubitemid 44846272)
24. Oliver-Vila I, Saborit-Villarroya I, Engel P, Martin M. The leukocyte receptor CD84 inhibits FcvarepsilonRI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells. Mol Immunol. 2008;45(8):2138-2149.
25. Ryan EJ, Marshall AJ, Magaletti D, et al. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J Immunol. 2002;169(10): 5638-5648. (Pubitemid 35291665)
26. Oh KI, Kim BK, Ban YL, et al. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med. 2007;39(2):176-184.
27. Kim N, Luster AD. Regulation of immune cells by eicosanoid receptors. Sci World J. 2007;7:1307-1328. (Pubitemid 47435438)
28. Prinz I, Gregoire C, Mollenkopf H, et al. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. J Immunol. 2005; 175(2):713-719. (Pubitemid 41094951)
29. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol. 2000;30(10):2972-2979. (Pubitemid 30786028)
30. De Fanis U, Mori F, Kurnat RJ, et al. GATA3 upregulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109(10):4343-4350. (Pubitemid 46743402)
31. Roufosse F. Clonal expansion of helper type 2 lymphocytes as a cause of the hypereosinophilic syndrome: clinical and immunological aspects [doctoral thesis]. Université Libre de Bruxelles, 2001.
32. Freishtat RJ, Mitchell LW, Ghimbovschi SD, Meyers SB, Hoffman EP. NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes. Hum Immunol. 2005;66(12):1223-1234.
33. van Doorn R, Dijkman R, Vermeer MH, et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res. 2004;64(16):5578-5586. (Pubitemid 39095552)
34. Gordon KJ, Blobe GC. Role of transforming growth factor-[beta] superfamily signaling pathways in human disease. Biochim Biophys Acta. 2008;1782(4):197-228.
35. Classen S, Zander T, Eggle D, et al. Human resting CD4+ T cells are constitutively inhibited by TGFbeta under steady-state conditions. J Immunol. 2007;178(11):6931-6940. (Pubitemid 46847419)
36. Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci U S A. 1994; 91(13):6002-6006. (Pubitemid 24188270)
37. Jelinek DF, Tschumper RC, Stolovitzky GA, et al. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res. 2003;1(5):346-361. (Pubitemid 36437921)
38. Bolkenius U, Hahn D, Gressner AM, Breitkopf K, Dooley S, Wickert L. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2004; 325(4):1264-1270. (Pubitemid 39535899)
39. Hager-Theodorides AL, Outram SV, Shah DK, et al. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol. 2002;169(10):5496-5504. (Pubitemid 35291647)
40. Kitisin K, Saha T, Blake T, et al. Tgf-Beta signaling in development. Sci STKE. 2007;399:cm1.
41. Blyth K, Vaillant F, Hanlon L, et al. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res. 2006;66(4):2195-2201. (Pubitemid 43294930)
42. Lee KB, Jeon JH, Choi I, Kwon OY, Yu K, You KH. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability. Biochem Biophys Res Commun. 2008;366(4):905-909.
43. Knoops L, Renauld JC. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors. 2004;22(4):207-215. (Pubitemid 40123399)
44. Marelli-Berg FM, Cannella L, Dazzi F, Mirenda V. The highway code of T cell trafficking. J Pathol. 2008;214(2):179-189.
45. Hung CH, Chu YT, Hua YM, et al. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells. Eur Respir J. 2008; 31(6):1313-1321.
46. Pals ST, de Gorter DJ, Spaargaren M. Lymphoma dissemination: the other face of lymphocyte homing. Blood. 2007;110(9):3102-3111. (Pubitemid 350106300)
47. Kanellopoulou C, Monticelli S. A role for micro- RNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008;18(2):79-88.
48. Shannan B, Seifert M, Boothman DA, Tilgen W, Reichrath J. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J Mol Histol. 2006;37(5): 183-188. (Pubitemid 44795623)
49. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147-152.
50. Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol. 2007;20(3):425-437. (Pubitemid 47260321)
51. Christoforidou AV, Papadaki HA, Margioris AN, Eliopoulos GD, Tsatsanis C. Expression of the Tpl2/Cot oncogene in human T-cell neoplasias. Mol Cancer. 2004;3(1):34. (Pubitemid 40230538)
52. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007;21(5):578-589.
53. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129(1):147-161. (Pubitemid 46507589)
54. Ringrose A, Zhou Y, Pang E, et al. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia. 2006;20(9):1593-1601. (Pubitemid 44264103)
55. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8):5082-5089.
56. Vaklavas C, Tefferi A, Butterfield J, et al. "Idiopathic" eosinophilia with an occult T-cell clone: prevalence and clinical course. Leuk Res. 2007; 31(5):691-694. (Pubitemid 46560006)
57. Bergua JM, Prieto-Pliego E, Roman-Barbera A, et al. Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation. Ann Hematol. 2008;87(11):937-938.
58. Ogawa K, Funaba M, Tsujimoto M. A dual role of activin A in regulating immunoglobulin production of B cells. J Leukoc Biol. 2008;83(6):1451-1458. (Pubitemid 351960326)
59. Babu G, Waterfield M, Chang M, Wu X, Sun SC. Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells. J Biol Chem. 2006;281(20):14041-14047 (Pubitemid 43848330)